tlooto

Impact of Sleep Positioning Device on Acid Exposure and Outcomes in Lung Transplant Recipients With Gastroesophageal Reflux Disease.

Manik Aggarwal, Lucy Thuita, Tyler Greathouse, J. Rappaport, Adam Kichler, Z. Arora, Yi L. Qin, O. Akindipe, Andrew Tang, Sudish P. Murthy, C. Lane, Marie Budev, Usman Ahmad, Scott L. Gabbard

2026.1.21Journal of Clinical Gastroenterology

Paper details

Journal
Journal of Clinical Gastroenterology
Published
2026.1.21
Citations
0
References
17
Fields
Medicine

tlooto Summary

Use of a novel SPD can stabilize or improve pulmonary function in patients with GERD after LT, and may be a safe and cost-effective adjunctive therapy for the management of GERD after LT.

Abstract

INTRODUCTION Gastroesophageal reflux disease (GERD) plays an important role in lung transplant (LT) outcomes. This study aims to evaluate the impact of a novel sleep positioning device (SPD) on lung function in LT recipients with GERD.

METHODS In this single-center cohort study, LT recipients (2014 to 2019) with GERD who were prescribed an SPD within 2 years of LT were included. A historical control group of LT recipients with GERD on PPI only (2011 to 2013) was selected to compare forced expiratory volume in 1 second (FEV1) as a marker of lung function.

RESULTS Twenty LT recipients using SPD (cases) and 54 patients in the historical control group with proven GERD were included. Mean (SD) interval between LT and SPD prescription was 8.6 (5.7) months. Mean % predicted FEV1 was higher in SPD users than controls post-LT at 6 months (80% vs. 69%) and 1 year (80% vs. 71%), respectively. Among SPD users, post-SPD FEV1 was higher than pre-SPD FEV1 (82% vs. 70%).

CONCLUSION Use of a novel SPD can stabilize or improve pulmonary function in patients with GERD after LT. SPD may be a safe and cost-effective adjunctive therapy for the management of GERD after LT.

Citation format

AGGARWAL, Manik, et al. Impact of sleep positioning device on acid exposure and outcomes in lung transplant recipients with gastroesophageal reflux disease. Journal of Clinical Gastroenterology, 2026, 60(7): 619–625.